• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中 c-MYC、AXIN1 和 COL11A1 基因表达的研究。

An investigation on the c-MYC, AXIN1, and COL11A1 gene expression in colorectal cancer.

机构信息

Departments of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Departments of Systems Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

出版信息

Biotechnol Appl Biochem. 2022 Aug;69(4):1576-1586. doi: 10.1002/bab.2229. Epub 2021 Aug 7.

DOI:10.1002/bab.2229
PMID:34319618
Abstract

The high incidence rate of CRC demands early diagnosis of the disease and readiness of diagnostic biomarker. In present study, we have investigated c-MYC, AXIN1, and COL11A1 expression levels in course of CRC progression and their correlation with demographics and clinical risk factors. Fifty-five tumors and 41 normal tissues were obtained from Tumor Bank of Iran, total RNA was extracted, cDNA was synthesized, and RT-qPCR was performed. Results were analyzed using Rest 2009 and SPSS software. Analysis at mRNA level showed upregulation of the two genes; c-MYC with a p-value of 0.001 and COL11A1 with an observed p-value of 0.02, while a p-value of 0.04 indicated AXIN1 downregulation. The observed overexpression of COL11A1 in stage 0 compared to other stages of CRC asserts importance of this gene in CRC prognosis. Moreover, statistical analysis confirms a significant correlation between expression of these genes and several clinical risk factors of CRC. Our study supports the importance of the studied genes and provides further information regarding the molecular mechanism of CRC. Further studies on these genes could elucidate their pivotal role for both early detection and/or diagnosis of CRC in addition to have important biomarkers for CRC management available.

摘要

CRC 的高发病率要求对疾病进行早期诊断,并准备好诊断生物标志物。在本研究中,我们研究了 CRC 进展过程中 c-MYC、AXIN1 和 COL11A1 的表达水平及其与人口统计学和临床危险因素的相关性。从伊朗肿瘤库获得了 55 个肿瘤和 41 个正常组织,提取总 RNA,合成 cDNA,并进行 RT-qPCR。使用 Rest 2009 和 SPSS 软件分析结果。mRNA 水平的分析表明这两个基因上调;c-MYC 的 p 值为 0.001,COL11A1 的观察到的 p 值为 0.02,而 AXIN1 的下调 p 值为 0.04。与 CRC 的其他阶段相比,COL11A1 在 0 期的过度表达表明该基因在 CRC 预后中的重要性。此外,统计学分析证实了这些基因的表达与 CRC 的几个临床危险因素之间存在显著相关性。我们的研究支持了所研究基因的重要性,并提供了有关 CRC 分子机制的进一步信息。对这些基因的进一步研究可以阐明它们在 CRC 的早期检测和/或诊断中的关键作用,以及为 CRC 管理提供重要的生物标志物。

相似文献

1
An investigation on the c-MYC, AXIN1, and COL11A1 gene expression in colorectal cancer.结直肠癌中 c-MYC、AXIN1 和 COL11A1 基因表达的研究。
Biotechnol Appl Biochem. 2022 Aug;69(4):1576-1586. doi: 10.1002/bab.2229. Epub 2021 Aug 7.
2
USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.USP44 通过 Axin1 去泛素化来抑制结直肠癌细胞的增殖并促进其凋亡,从而阻断 Wnt/β-catenin 通路。
Cell Biol Int. 2020 Aug;44(8):1651-1659. doi: 10.1002/cbin.11358. Epub 2020 Apr 21.
3
Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancers.胶原 1A1(COL1A1)和胶原 11A1(COL11A1)作为乳腺癌、结直肠癌和胃癌的诊断生物标志物。
Gene. 2024 Jan 20;892:147867. doi: 10.1016/j.gene.2023.147867. Epub 2023 Oct 1.
4
Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.c-MYC与β-连环蛋白共表达的结直肠癌患者预后良好。
BMC Cancer. 2016 Sep 13;16(1):730. doi: 10.1186/s12885-016-2770-7.
5
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.FBXW7 缺失与结直肠癌:临床意义。(注:FBXW7 是一种细胞周期调节基因)
Int J Cancer. 2010 Apr 15;126(8):1828-1837. doi: 10.1002/ijc.24879.
6
COL11A1 in FAP polyps and in sporadic colorectal tumors.FAP息肉和散发性结直肠癌肿瘤中的COL11A1。
BMC Cancer. 2001;1:17. doi: 10.1186/1471-2407-1-17. Epub 2001 Oct 29.
7
Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells.结直肠癌细胞中诱导多能干细胞相关基因表达的临床意义综合分析
Ann Surg Oncol. 2009 Sep;16(9):2638-44. doi: 10.1245/s10434-009-0567-5. Epub 2009 Jun 25.
8
COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.COL11A1在胃癌组织中过表达,并在体外调节HGC-27胃癌细胞的增殖、迁移和侵袭。
Oncol Rep. 2017 Jan;37(1):333-340. doi: 10.3892/or.2016.5276. Epub 2016 Nov 25.
9
The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of Axin1.E3 泛素连接酶 RNF146 通过泛素化 Axin1 激活 Wnt/β-连环蛋白通路促进结直肠癌。
Biochem Biophys Res Commun. 2018 Sep 5;503(2):991-997. doi: 10.1016/j.bbrc.2018.06.107. Epub 2018 Jun 25.
10
Development of novel real-time RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens.开发用于定量COL11A1 mRNA通用型和C转录本的新型实时逆转录定量聚合酶链反应方法并在非小细胞肺癌标本中进行评估。
J BUON. 2018 Nov-Dec;23(6):1699-1710.

引用本文的文献

1
Inhibition of colorectal cancer cell growth by downregulation of M2-PK and reduction of aerobic glycolysis by clove active ingredients.通过下调M2-PK抑制结肠癌细胞生长以及通过丁香活性成分减少有氧糖酵解
Front Pharmacol. 2025 Apr 16;16:1552486. doi: 10.3389/fphar.2025.1552486. eCollection 2025.
2
The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker.COL11A1表达在乳腺癌发生发展过程中的动态变化及其作为候选诊断和预后标志物的研究
Breast J. 2025 Jan 10;2025:7861864. doi: 10.1155/tbj/7861864. eCollection 2025.
3
[Genetic drivers for inflammatory protein markers in colorectal cancer: a Mendelian randomization approach to clinical prognosis study].
[结直肠癌炎症蛋白标志物的遗传驱动因素:临床预后研究的孟德尔随机化方法]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1361-1369. doi: 10.12122/j.issn.1673-4254.2024.07.16.
4
Ischemia-reperfusion injury in human AC16 cardiomyocytes is modulated by AXIN1 depending on c-Myc regulation.人AC16心肌细胞中的缺血再灌注损伤由AXIN1根据c-Myc调节进行调控。
Ann Med Surg (Lond). 2023 Aug 7;85(10):4844-4850. doi: 10.1097/MS9.0000000000001139. eCollection 2023 Oct.
5
Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties.经皮冠状动脉介入治疗(PCI)重编程急性冠脉综合征(ACS)患者的循环细胞外囊泡,损害其心脏保护特性。
Int J Mol Sci. 2021 Sep 24;22(19):10270. doi: 10.3390/ijms221910270.